MISSISSAUGA, ON, Oct. 27, 2016 /PRNewswire/ - Cipher
Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) today announced it will
host a conference call for its Q3 2016 financial results
on Friday, November 11, 2016.
Q3 2016 CONFERENCE CALL
WHEN: Friday, November 11, 2016 at 8:30AM
ET
CONFERENCE CALL/WEBCAST: You can join the call by dialing
647-427-7450 or 1-888-231-8191. A live audio webcast will be
available through www.cipherpharma.com or
http://bit.ly/2ekaMxk. An archived replay of the webcast will
be available for 90 days.
About Cipher Pharmaceuticals Inc.
Cipher
Pharmaceuticals (NASDAQ:CPHR;TSX:CPH) is a rapidly growing
specialty pharmaceutical dermatology company with a diversified
portfolio of commercial-stage products with the goal of becoming
the most customer-centric dermatology company in North
America.
Through multiple transactions, including the acquisition of
Innocutis and its nine branded dermatology products, Cipher has
built its U.S. commercial presence, expanded its Canadian
dermatology franchise and broadened its pipeline. Cipher is
well-capitalized to drive long-term, sustained earnings growth by
leveraging its proven clinical development capabilities and
efficient commercial execution. For more information,
visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.